170 related articles for article (PubMed ID: 27661766)
1. Decreased Level of Klotho Contributes to Drug Resistance in Lung Cancer Cells: Involving in Klotho-Mediated Cell Autophagy.
Chen T; Ren H; Thakur A; Yang T; Li Y; Zhang S; Wang T; Chen M
DNA Cell Biol; 2016 Dec; 35(12):751-757. PubMed ID: 27661766
[TBL] [Abstract][Full Text] [Related]
2. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
3. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.
Zhang Q; Zhu H; Xu X; Li L; Tan H; Cai X
Biochem Biophys Res Commun; 2015 Sep; 465(1):64-70. PubMed ID: 26235873
[TBL] [Abstract][Full Text] [Related]
4. Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway.
Wang Y; Chen L; Huang G; He D; He J; Xu W; Zou C; Zong F; Li Y; Chen B; Wu S; Zhao W; Wu J
PLoS One; 2013; 8(2):e57391. PubMed ID: 23437382
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
[TBL] [Abstract][Full Text] [Related]
6. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
7. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy.
Ren JH; He WS; Nong L; Zhu QY; Hu K; Zhang RG; Huang LL; Zhu F; Wu G
Cancer Biother Radiopharm; 2010 Feb; 25(1):75-80. PubMed ID: 20187799
[TBL] [Abstract][Full Text] [Related]
8. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
Ma Y; Li X; Cheng S; Wei W; Li Y
Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
[TBL] [Abstract][Full Text] [Related]
10. GAS5 modulated autophagy is a mechanism modulating cisplatin sensitivity in NSCLC cells.
Zhang N; Yang GQ; Shao XM; Wei L
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2271-7. PubMed ID: 27338051
[TBL] [Abstract][Full Text] [Related]
11. Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma.
Wang R; Huang J; Feng B; De W; Chen L
Mol Med; 2012 Jul; 18(1):874-86. PubMed ID: 22460125
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1.
Shen C; Wang W; Tao L; Liu B; Yang Z; Tao H
Int J Mol Med; 2013 Aug; 32(2):448-56. PubMed ID: 23722646
[TBL] [Abstract][Full Text] [Related]
13. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
15. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
16. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
[TBL] [Abstract][Full Text] [Related]
17. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
[TBL] [Abstract][Full Text] [Related]
18. HMGB1 Enhances Drug Resistance and Promotes In Vivo Tumor Growth of Lung Cancer Cells.
Zheng H; Chen JN; Yu X; Jiang P; Yuan L; Shen HS; Zhao LH; Chen PF; Yang M
DNA Cell Biol; 2016 Oct; 35(10):622-627. PubMed ID: 27383136
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X
Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
[TBL] [Abstract][Full Text] [Related]
20. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
